Özakbaş, S. Et Al. 2021. Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results. ECTRIMS , (Vienna, Austria), 278.

Özakbaş, S., Özçelik, S., Kaya, E., Özdoğar, A. T., Sağıcı, Ö., & Baba, C., (2021). Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results . ECTRIMS (pp.278). Vienna, Austria

Özakbaş, SERKAN Et Al. "Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results," ECTRIMS, Vienna, Austria, 2021

Özakbaş, SERKAN Et Al. "Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results." ECTRIMS , Vienna, Austria, pp.278, 2021

Özakbaş, S. Et Al. (2021) . "Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results." ECTRIMS , Vienna, Austria, p.278.

@conferencepaper{conferencepaper, author={SERKAN ÖZAKBAŞ Et Al. }, title={Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results}, congress name={ECTRIMS}, city={Vienna}, country={Austria}, year={2021}, pages={278} }